- Filed
- May 14, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · May 14, 2025 | 229.16M sh |
| Cash And Equivalents | Q2 2025 · Mar 31, 2025 | $720.01K |
| Cash And Equivalents | Q2 2025 · Sep 30, 2024 | $849.73K |
| Total Liabilities | Q2 2025 · Mar 31, 2025 | $1.53M |
| Total Liabilities | Q2 2025 · Sep 30, 2024 | $1.5M |
| Current Assets | Q2 2025 · Mar 31, 2025 | $1.17M |
| Current Assets | Q2 2025 · Sep 30, 2024 | $1.2M |
| Total Assets | Q2 2025 · Mar 31, 2025 | $1.25M |
| Total Assets | Q2 2025 · Sep 30, 2024 | $1.3M |
| Shares Diluted | Q2 2025 · Mar 31, 2024 | 599.48M sh |
| Shares Diluted | Q2 2025 · Mar 31, 2024 | 599.48M sh |
| Operating Cash Flow | Q2 2025 · Mar 31, 2024 | $290.26K |
| Stockholders Equity restated | Q2 2025 · Mar 31, 2024 | $43.06K |
| Stockholders Equity | Q2 2025 · Dec 31, 2023 | $22.84K |
| Stockholders Equity | Q2 2025 · Sep 30, 2023 | $5.18K |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | $0.00 |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | $0.00 |
| Eps Basic | Q2 2025 · Mar 31, 2024 | $0.00 |
| Eps Basic | Q2 2025 · Mar 31, 2024 | $0.00 |
| Sga Expense restated | Q2 2025 · Mar 31, 2024 | $361.09K |
| Sga Expense | Q2 2025 · Mar 31, 2024 | $765.98K |
| Rd Expense | Q2 2025 · Mar 31, 2024 | $3.04K |
| Rd Expense | Q2 2025 · Mar 31, 2024 | $16.6K |
| Net Income | Q2 2025 · Mar 31, 2024 | $20.22K |
| Net Income restated | Q2 2025 · Mar 31, 2024 | $37.88K |
| Gross Profit restated | Q2 2025 · Mar 31, 2024 | $394.4K |
| Gross Profit restated | Q2 2025 · Mar 31, 2024 | $904.81K |
| Cost Of Revenue restated | Q2 2025 · Mar 31, 2024 | $177.62K |
| Cost Of Revenue restated | Q2 2025 · Mar 31, 2024 | $273.25K |
| Revenue | Q2 2025 · Mar 31, 2024 | $572.01K |
| Revenue | Q2 2025 · Mar 31, 2024 | $1.18M |